Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites

Clinical trial NCT01349348 · COMPLETED

Trial details

NCT number: NCT01349348
Sponsor: Otsuka Beijing Research Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ascites Hepatic Cirrhosis

Start date: 2010-10-01
Primary completion: 2012-05-01
Enrollment: 535

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.